SCHEMBL5780658

SCHEMBL5780658

COC(=O)CC(CC(=O)OC)c1ccc2c(c1)CCCN2

nearest known ligand 0.48

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
GAA P10253 3/20 0.48
MAPT P10636 3/20 0.48
KDM4E B2RXH2 2/20 0.48
ALDH1A1 P00352 3/20 0.42
LMNA P02545 1/20 0.42
TP53 P04637 1/20 0.42
THRB P10828 1/20 0.42
ALOX15 P16050 1/20 0.42
CASP1 P29466 1/20 0.42
HTT P42858 1/20 0.42
CASP7 P55210 1/20 0.42
HSD17B10 Q99714 1/20 0.42
TDP1 Q9NUW8 1/20 0.42
TSHR P16473 1/20 0.42
PPARG P37231 2/20 0.41
PPARD Q03181 2/20 0.41
PPARA Q07869 2/20 0.41
CA12 O43570 1/20 0.41
CA1 P00915 1/20 0.41
CA2 P00918 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5781700 0.80 ITGB3 (0.48) MAPTKDM4EITGB3ITGAV
SCHEMBL5781701 0.80 ITGB3 (0.48) MAPTKDM4EITGB3ITGAV
SCHEMBL5781661 0.79 ITGB3 (0.51) ITGB3ITGAV
SCHEMBL5781663 0.79 ITGB3 (0.51) ITGB3ITGAV
SCHEMBL7717114 0.77 KDM4E (0.51) GAAMAPTKDM4EALDH1A1LMNA
SCHEMBL5778799 0.76 MAPT (0.54) GAAMAPTKDM4EALDH1A1LMNA
SCHEMBL5778803 0.76 MAPT (0.54) GAAMAPTKDM4EALDH1A1LMNA
SCHEMBL29679157 0.75 GAA (0.49) GAAMAPTKDM4EALDH1A1LMNA
SCHEMBL16595914 0.75 GAA (0.49) GAAMAPTKDM4EALDH1A1LMNA
SCHEMBL45146 0.75 MAPT (0.68) GAAMAPTKDM4EALDH1A1LMNA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1114028-B1 AZA-BICYCLES WHICH MODULATE THE INHIBITION OF CELL ADHESION AVENTIS PHARMA LTD (GB) 2006-11-29 EP disclosed
US-6608084-B1 Treatment of human or non-human animal patient suffering from, or subject to, condition which can be ameliorated by administration of inhibitor of alpha 4 beta 1 mediated cell adhesion AVENTIS PHARMA LTD. (GB) 2003-08-19 US disclosed
EP-1114028-A1 AZA-BICYCLES WHICH MODULATE THE INHIBITION OF CELL ADHESION Aventis Pharma Limited (GB) 2001-07-11 EP disclosed
WO-2000015612-A1 AZA-BICYCLES WHICH MODULATE THE INHIBITION OF CELL ADHESION AVENTIS PHARMA LIMITED (GB) 2000-03-23 WO disclosed